[Form 4] DOCUSIGN, INC. Insider Trading Activity

Rhea-AI Filing Summary

Anna Marrs, a Director of DocuSign, Inc. (DOCU), reported a sale of company stock under a pre-established trading plan. On 09/15/2025 she disposed of 728 shares of DocuSign common stock at a reported price of $80.3 per share. After the sale she beneficially owned 10,799 shares, held directly. The filing notes the transaction was effected pursuant to a Rule 10b5-1 plan. The Form 4 was signed by an attorney-in-fact on 09/16/2025.

Positive

• Transaction was executed under a Rule 10b5-1 plan, indicating it was pre-established
• Prompt disclosure with Form 4 filed and signed by attorney-in-fact dated 09/16/2025

Negative

• Director disposed of 728 shares, reducing direct beneficial ownership (now 10,799 shares)
• No information on total percentage ownership or relation of this sale to overall holdings in the company

Insights

Financial Analyst

TL;DR: Routine insider sale under a 10b5-1 plan; small reduction in direct holdings relative to total shares outstanding.

The reported transaction is a straightforward disposition of 728 shares at $80.3 each executed under a Rule 10b5-1 plan, indicating it was pre-planned and not an ad-hoc sale. Post-transaction direct beneficial ownership is 10,799 shares. The filing does not disclose option exercises, derivative activity, or any other changes to holdings. From an analytical perspective, this Form 4 provides clear, limited disclosure of a single routine sale by a director.

Corporate Governance Expert

TL;DR: Governance-compliant disclosure; use of 10b5-1 shows adherence to insider trading protocols.

The Form 4 documents compliance with Section 16 reporting and cites a Rule 10b5-1 plan, which typically mitigates concerns about opportunistic insider trading. The sale was executed and reported promptly with an attorney-in-fact signature dated 09/16/2025. The filing contains no indications of related-party transactions or amendments. For governance review, this is a routine, transparent insider sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Marrs Anna

(Last) (First) (Middle)

C/O DOCUSIGN, INC.

221 MAIN STREET, SUITE 800

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DOCUSIGN, INC. [ DOCU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2025		S		728(1)	D	$80.3	10,799	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

Remarks:

	/s/ Derrick Chapman, Attorney-in-fact	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DOCU director Anna Marrs report on Form 4?

She reported a sale of 728 shares of DocuSign common stock on 09/15/2025 executed under a Rule 10b5-1 plan.

At what price were the DOCU shares sold?

The reported price was $80.3 per share for the 728-share disposition.

How many DocuSign shares does Anna Marrs beneficially own after the transaction?

She beneficially owned 10,799 shares directly following the reported transaction.

Does the Form 4 indicate the sale was pre-planned?

Yes. The filing states the transaction was effected pursuant to a Rule 10b5-1 plan.

Who signed the Form 4 and when?

The form was signed by an attorney-in-fact, Derrick Chapman, on 09/16/2025.